Alzheimer's and the spread of tau protein.. How did scientists reveal the role of water in the progression of the disease?

The results do not mean that water causes the disease, but rather highlight its role in the molecular environment surrounding the protein, and how the properties of this environment can contribute to the formation of protein aggregates linked to the progression of the disease.

In the brains of Alzheimer's patients, abnormal changes appear in several proteins, most notably "amyloid-beta" and "tau." The exact relationship between these changes and the onset and progression of the disease remains a subject of ongoing scientific research.

Under normal conditions, the tau protein plays an important role in supporting the internal structure of nerve cells. However, when its shape and the way it interacts with surrounding molecules change, it can aggregate into abnormal fibrous structures known as "tau fibrils."

These aggregates are associated with the disruption and deterioration of nerve cell functions, and abnormal forms of the protein can also move between cells, which may contribute to the spread of pathological changes within the brain.

The researchers focused on a specific region in the tau protein that they described as a "hot spot," due to its role in the interactions that help proteins bind to each other.

This region is characterized by hydrophobic properties, meaning its interaction with water molecules differs from the interaction of hydrophilic regions. These properties may help determine how proteins approach each other and form more stable aggregates.

Songi Han, a professor of physical chemistry at Northwestern University, explained that water molecules interact with this region in a way that affects the stability of the protein and its interaction with other similar molecules.

The importance of this discovery lies in the fact that it highlights the role of the environment surrounding the protein, rather than viewing the tau protein as a molecule that operates in isolation from water and other molecules.

The formation of fibrils requires the alignment of tau molecules in a precise way that allows them to bind and grow into fibrous structures. According to the results reported by the researchers, disrupting this alignment can hinder the fibril formation process.

Experiments also showed that chemically modifying the region in question can limit the continued formation of these structures, suggesting that intervention at this stage could be a potential way to influence the clumping process.

This finding is significant because it helps scientists identify specific molecular sites that can be studied to explore ways to disrupt the aggregation of abnormal proteins.

Identifying the region responsible for initiating clumping opens up an area for searching for drug compounds that can influence tau protein interactions or limit its ability to form fibrils.

Theoretically, this approach could help in the future to slow down some of the processes associated with nerve cell degeneration, if safe and effective interventions targeting the discovered mechanism can be developed.

However, the road from discovering a molecular mechanism in the laboratory to producing a treatment available to patients is long; it requires verifying the results, testing potential compounds, and then evaluating their safety and efficacy in clinical studies.

The researchers also suggested using synthetic tau fibrils to study the stages of clumping with greater precision,